A recent systematic review suggested that GGT could be detected in the peripheral blood of patients with advanced genitourinary cancer particularly when cancer cells had high GGT expression, the disease was advanced, or the tumor burden was heavy [15]. The gene discussed is GGT1; the disease is urogenital neoplasm.